Multi-drug Resistant Tuberculosis: Clinical Trials

1 trial for Multi-drug Resistant Tuberculosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Unknown 1
Phase 31Unknown 1

Follow Multi-drug Resistant Tuberculosis: new trials by email Literature Review of Multi-drug Resistant Tuberculosis trials Research Report on Multi-drug Resistant Tuberculosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PRACTECAL-PKPD Sub Study
Bedaquiline, Pretomanid, Moxifloxacin - Multi-drug Resistant Tuberculosis, Extensively Drug-Resistant Tuberculosis
Phase 2 / Phase 3UnknownMedecins Sans Frontieres, Netherlands2402019-08-062021-05-14

Narrower conditions

Extensively Drug-Resistant Tuberculosis (1)  ·  Tuberculosis, Multidrug-Resistant (1)  ·  Tuberculosis, Pulmonary (1)

Broader conditions

Actinomycetales Infections (1)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Gram-Positive Bacterial Infections (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Mycobacterium Infections (1)  ·  Respiratory Tract Diseases (1)  ·  Respiratory Tract Infections (1)  ·  Tuberculosis (1)

Interventions

Clofazimine (1)  ·  Linezolid (1)  ·  Moxifloxacin (1)  ·  bedaquiline (1)  ·  pretomanid (1)

Sponsors

Medecins Sans Frontieres, Netherlands (1)

Countries

Belarus (1)  ·  South Africa (1)

Top investigators

Bern Nyang'wa, MB BS, MPH (1)

Results publications

PMID 34489274, PMID 41917253, PMID 42270675